Home>>Signaling Pathways>> Endocrinology and Hormones>> Androgen Receptor>>GSK2881078

GSK2881078

Catalog No.GC17679

selective androgen receptor modulator (SARM)

Products are for research use only. Not for human use. We do not sell to patients.

GSK2881078 Chemical Structure

Cas No.: 1539314-06-1

Size Price Stock Qty
5mg
$72.00
In stock
10mg
$117.00
In stock
25mg
$234.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

GSK2881078 is a potent and selective androgen receptor modulator (SARM) [1].

Steroidal nuclear receptor (NR) ligands play important roles in the health of both men and women. Dihydrotestosterone (DHT) and testosterone (T) are endogenous steroidal ligands for the androgen receptor (AR) that play a role in every tissue type found in the mammalian body. During the development of the fetus, androgens play an important role in sexual differentiation and development of male sexual organs. SARMs are small molecule pharmacotherapeutics that have the potential to afford the important benefits of androgen therapy without the undesired side-effects [1].

GSK2881078 is a potent and selective androgen receptor modulator (SARM) that is being evaluated for effects on muscle growth and strength in subjects with muscle wasting to improve their physical function. GSK2881078 is currently in phase I clinical trials [1].

Reference:
[1].  https://newdrugapprovals.org/2016/06/14/gsk-2881078/

Reviews

Review for GSK2881078

Average Rating: 5 ★★★★★ (Based on Reviews and 22 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for GSK2881078

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.